Membrane transport of chemotherapeutics and drug resistance: Beyond the ABC family of exporters to the role of carrier-mediated processes

Clinical Cancer Research

Volumn 8, Issue 1, 2002, Pages 4-6

  Goldman, I David ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AMINO ACID; ANION; ANTHRACYCLINE; ANTIMETABOLITE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; CATION; CISPLATIN; DNA TOPOISOMERASE INHIBITOR; DRUG CARRIER; FATTY ACID; FOLIC ACID ANTAGONIST; GLUCURONIDE; GLUTATHIONE DERIVATIVE; GLYCOPROTEIN P; METAL; METHOTREXATE; MULTIDRUG RESISTANCE PROTEIN; NUCLEIC ACID BASE; NUCLEOSIDE; NUCLEOTIDE; OLIGOPEPTIDE; SUGAR; TAXANE DERIVATIVE; VINCA ALKALOID; VITAMIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL CYCLE; DRUG DIFFUSION; DRUG RESPONSE; EDITORIAL; LIPOPHILICITY; MEMBRANE TRANSPORT; NUCLEOSIDE TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; TUMOR CELL;

AFFINITY LABELS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT; DRUG RESISTANCE, NEOPLASM; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; HUMANS; MEMBRANE TRANSPORT PROTEINS; NEOPLASM PROTEINS; NEOPLASMS;

EID: 0036152432     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Identification of the major intestinal fatty acid transport protein
2. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein
3. The cellular pharmacology of methotrexate
4. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression
5. Reduced folate carrier gene expression in childhood acute lymphoblastic leukemia: Relationship to immunophenotype and ploidy
6. Mechanisms of methotrexate resistance in osteosarcoma
7. Cellular pharmacokinetics of the phenylalanine mustards
8. Phylogeny of multidrug transporters
9. From MDR to MXR: New understanding of multidrug resistance systems, their properties and clinical significance
10. A family of drug transporters: The multidrug resistance-associated proteins
11. The multidrug resistance protein family
12. The major facilitator superfamily
13. The ENT family of eukaryote nucleoside and nucleobase transporters: Recent advances in the investigation of structure/function relationships and the identification of novel isoforms
14. +-dependent nucleoside transporter (CNT) family: Identification and characterization of novel human and mouse proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides
15. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines
16. Nucleoside transport and its significance for anticancer drug resistance
17. Current status of gemcitabine in the treatment of cancer
18. Pemetrexed disodium, a novel antifolate with multiple targets
19. Sensitivity to 5,10-dideazatetrahydrofolate is fully conserved in a murine leukemia cell line highly resistant to methotrexate due to impaired transport mediated by the reduced folate carrier
20. The mechanism of transport of the multitargeted antifolate, MTA-LY231514, and its cross resistance pattern in cell with impaired transport of methotrexate
21. Recent advances in understanding of the mechanism of membrane transport of folates and antifolates
22. Transporters involved in the elimination of drugs in the kidney: Organic anion transporters and organic cation transporters
23. Membrane transporters
24. Cancer celltargeted drug delivery utilizing oligopeptide transport activity
25. Molecular and functional characteristics of cloned human organic cation transporters